Cardiometabolic profile and cardiorenal complications across BMI categories in type 2 diabetes: A nationwide real-world analysis of over 500,000 patients.
文献摘要
Aims Patients with T2D exhibit substantial heterogeneity across the BMI spectrum. We aimed to characterize cardiometabolic profiles, treatment patterns, and complication burden and to assess the association between BMI categories and major cardiorenal complications. Methods We conducted a cross-sectional analysis of 519,005 adults with T2D attending 296 Italian diabetes centers in 2023. Clinical characteristics, comorbidities, and treatment patterns were compared across standard WHO BMI cut-offs. Associations between BMI category and coronary artery disease, heart failure (HF), cerebrovascular disease, peripheral artery disease, and chronic kidney disease (CKD) were evaluated using multivariable models. Results Obesity was present in 35.4% of the patients and overweight in 39.1%. Despite similar HbA1c levels, cardiometabolic risk factors progressively worsened across BMI categories. Patients with obesity were younger, with shorter diabetes duration and lower crude rates of most cardiovascular complications. After adjustment, obesity was associated with CKD (PR 1.13, p Conclusions In this large real-world T2D cohort, the lower crude prevalence of cardiovascular complications in patients with obesity was partly explained by confounding factors. Obesity was associated with a higher prevalence of CKD and HF, highlighting the importance of weight-centred approaches and comprehensive cardiorenal risk assessment in T2D.